These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33421915)

  • 1. Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents.
    Amblard F; Boucle S; Bassit L; Chen Z; Sari O; Cox B; Verma K; Ozturk T; Ollinger-Russell O; Schinazi RF
    Bioorg Med Chem; 2021 Feb; 31():115952. PubMed ID: 33421915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses
    Amblard F; Boucle S; Bassit L; Cox B; Sari O; Tao S; Chen Z; Ozturk T; Verma K; Russell O; Rat V; de Rocquigny H; Fiquet O; Boussand M; Di Santo J; Strick-Marchand H; Schinazi RF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.
    Sari O; Boucle S; Cox BD; Ozturk T; Russell OO; Bassit L; Amblard F; Schinazi RF
    Eur J Med Chem; 2017 Sep; 138():407-421. PubMed ID: 28688280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.
    Hurwitz SJ; McBrearty N; Arzumanyan A; Bichenkov E; Tao S; Bassit L; Chen Z; Kohler JJ; Amblard F; Feitelson MA; Schinazi RF
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33467678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
    Revill P; Locarnini S
    Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
    Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
    Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q
    Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Discovery of
    Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status and future directions of hepatitis B antiviral drug discovery.
    Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT
    Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines.
    Gerasi M; Frakolaki E; Papadakis G; Chalari A; Lougiakis N; Marakos P; Pouli N; Vassilaki N
    Bioorg Chem; 2020 May; 98():103580. PubMed ID: 32005482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity.
    Yamashita A; Tamaki M; Kasai H; Tanaka T; Otoguro T; Ryo A; Maekawa S; Enomoto N; de Voogd NJ; Tanaka J; Moriishi K
    Antiviral Res; 2017 Sep; 145():136-145. PubMed ID: 28827084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
    Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
    J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA.
    Liu C; Cai D; Zhang L; Tang W; Yan R; Guo H; Chen X
    Antiviral Res; 2016 Oct; 134():97-107. PubMed ID: 27591143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].
    Lu HY; Zhuang LW; Yu YY; Si CW; Li J
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):198-202. PubMed ID: 18364079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators.
    Hwang N; Ban H; Wu S; McGuire K; Hernandez E; Chen J; Zhao Q; Suresh M; Blass B; Viswanathan U; Kulp J; Chang J; Clement J; Menne S; Guo JT; Du Y
    Bioorg Med Chem Lett; 2022 Feb; 58():128518. PubMed ID: 34979256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
    Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.